Singapore biotech firm secures USD 100 million via share subscription facility deal

Austrianova, a biotech company with operations in Singapore and Thailand, said it has signed an agreement with European alternative investment group Global Emerging Markets (GEM) Global Yield for a share subscription facility of up to USD 100 million for a 36-month term following a public listing. The deal allows Austrianova to draw down funds from the facility by issuing shares…
« Previous post: | Next post: »